Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Pharmabiz
47m
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers
EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers ...
2h
Immutep (ASX:IMM) announces positive results in head and neck cancer treatment
Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company's latest results in head and neck cancer.
5h
This US stock is crushing Nvidia's performance this year: Is it too late to buy?
Few companies have attracted more attention this year than Nvidia. The chipmaker is on a roll thanks to the rapid rise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Alabama mass shooting
Daylight saving time
Visits US ammunition plant
San Francisco homelessness
Released after guilty plea
Ga. suspect's mom indicted
Dolphins legend Morris dies
Trump to campaign in MI
Sesame Place suit verdict
Economic speech this week
Robinson loses key staff
No govt. shutdown for now
California plastic bag ban
Free COVID-19 tests
CA firefighter held for arson
PM Modi visits US
Hezbollah rockets hit Israel
Iran coal mine blast
J&J unit files for bankruptcy
CA bill to protect kids online
Donlon's homes searched
Suns broadcaster dies
TN abortion law blocked
Drug price challenge revived
Pandas leaving for China
Biden hosts 'Quad' summit
No. 1 at box office again
Former WA governor dies
Boeing defense chief exits
SC 1st execution in 13 years
ISR raids Al Jazeera office
Related topics
Pembrolizumab
Lung cancer
United States
Summit Therapeutics
Food and Drug Administration
Feedback